BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17294451)

  • 1. Circulating KL-6/MUC1 mucin carrying sialyl Lewisa oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma.
    Inata J; Hattori N; Yokoyama A; Ohshimo S; Doi M; Ishikawa N; Hamada H; Kohno N
    Int J Cancer; 2007 Jun; 120(12):2643-9. PubMed ID: 17294451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucins carrying selectin ligands as predictive biomarkers of disseminated intravascular coagulation complication in ARDS.
    Nakashima T; Yokoyama A; Inata J; Ishikawa N; Haruta Y; Hattori N; Kohno N
    Chest; 2011 Feb; 139(2):296-304. PubMed ID: 20671055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sialyl lewis X-i antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival.
    Satoh H; Ishikawa H; Kamma H; Yamashita YT; Takahashi H; Ohtsuka M; Hasegawa S
    Clin Cancer Res; 1997 Apr; 3(4):495-9. PubMed ID: 9815711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
    Ishikawa N; Hattori N; Yokoyama A; Tanaka S; Nishino R; Yoshioka K; Ohshimo S; Fujitaka K; Ohnishi H; Hamada H; Arihiro K; Kohno N
    Int J Cancer; 2008 Jun; 122(11):2612-20. PubMed ID: 18324627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma.
    Baldus SE; Mönig SP; Hanisch FG; Zirbes TK; Flucke U; Oelert S; Zilkens G; Madejczik B; Thiele J; Schneider PM; Hölscher AH; Dienes HP
    Histopathology; 2002 May; 40(5):440-9. PubMed ID: 12010364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new serum tumor marker, CAM 123-6, highly specific to pulmonary adenocarcinoma.
    Hamada H; Kohno N; Hiwada K
    Jpn J Cancer Res; 1994 Feb; 85(2):211-9. PubMed ID: 8144402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer.
    Hirasawa Y; Kohno N; Yokoyama A; Kondo K; Hiwada K; Miyake M
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):589-94. PubMed ID: 10673204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
    Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
    Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9.
    Kohno N; Inoue Y; Hamada H; Fujioka S; Fujino S; Yokoyama A; Hiwada K; Ueda N; Akiyama M
    Int J Cancer Suppl; 1994; 8():81-3. PubMed ID: 8194900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis.
    Yokoyama A; Kondo K; Nakajima M; Matsushima T; Takahashi T; Nishimura M; Bando M; Sugiyama Y; Totani Y; Ishizaki T; Ichiyasu H; Suga M; Hamada H; Kohno N
    Respirology; 2006 Mar; 11(2):164-8. PubMed ID: 16548901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.
    Hanski C; Hanski ML; Zimmer T; Ogorek D; Devine P; Riecken EO
    Cancer Res; 1995 Feb; 55(4):928-33. PubMed ID: 7850810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel monoclonal antibody, H9, directed against the core protein of MUC1 mucin.
    Hamada H; Kohno N; Yokoyama A; Kondo K; Yang SZ; Hiwada K; Watanabe K; Miyake M
    Oncol Rep; 2000; 7(2):225-32. PubMed ID: 10671662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.
    Rabassa ME; Croce MV; Pereyra A; Segal-Eiras A
    BMC Cancer; 2006 Oct; 6():253. PubMed ID: 17064405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance.
    Laack E; Nikbakht H; Peters A; Kugler C; Jasiewicz Y; Edler L; Brümmer J; Schumacher U; Hossfeld DK
    J Clin Oncol; 2002 Nov; 20(21):4279-84. PubMed ID: 12409325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma.
    Kohno N; Akiyama M; Kyoizumi S; Hakoda M; Kobuke K; Yamakido M
    Jpn J Clin Oncol; 1988 Sep; 18(3):203-16. PubMed ID: 3411786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells.
    Zhang K; Baeckström D; Brevinge H; Hansson GC
    J Cell Biochem; 1996 Mar; 60(4):538-49. PubMed ID: 8707893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases.
    Satoh H; Kurishima K; Ishikawa H; Ohtsuka M
    J Intern Med; 2006 Nov; 260(5):429-34. PubMed ID: 17040248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel classification of MUC1 expression is correlated with tumor differentiation and postoperative prognosis in non-small cell lung cancer.
    Nagai S; Takenaka K; Sonobe M; Ogawa E; Wada H; Tanaka F
    J Thorac Oncol; 2006 Jan; 1(1):46-51. PubMed ID: 17409826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.